QuantBioRes A/S: Financial statements 2021
CVR: 41407352
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
QuantBioRes A/S (CVR 41407352) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -2,907,012 and a net result of DKK -2,345,335. Equity in the 2021 report amounted to DKK -2,945,968.
- Gross Profit
- DKK -2,907,012
- Profit/Loss
- DKK -2,345,335
- Equity
- DKK -2,945,968
- Total Assets
- DKK 1,080,932
Official annual report
Find more companies like QuantBioRes A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
QuantBioRes A/S has published its interim report for the period June 3, 2020 – December 31, 2020.
As of June 15, 2021, AIDER Godkendt Revisionsaktieselskab has been appointed auditor of QuantBioRes A/S.
As of June 15, 2021, Grant Thornton, Godkendt Revisionspartnerselskab has stepped down as auditor of QuantBioRes A/S.
About QuantBioRes A/S
QuantBioRes A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2020. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Ivan Loncarevic. The board consists of Anthony Slingsby, Mark Andrew Madden and Novak Djokovic. The company is owned by Tulua Doo Beograd - Stari Grad, Anthony Charles Slingsby and Anna Eva Charlotta Slingsby. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -2,736,412 and a net result of DKK -2,396,479 compared with DKK -1,482,065 the year before. Equity in the 2025 report amounted to DKK 444,094.